Compounds > ellipticine

ellipticine and valproic acid

ellipticine has been researched along with valproic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dvorakova, M; Eckschlager, T; Frei, E; Göttlicherova, M; Hrabeta, J; Hrebackova, J; Kizek, R; Kopejtkova, B; Moserova, M; Poljakova, J; Stiborova, M1
Arlt, VM; Cerna, T; Eckschlager, T; Frei, E; Hrabeta, J; Schmeiser, HH; Stiborová, M1

Other Studies

2 other study(ies) available for ellipticine and valproic acid

ArticleYear
Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.
    Neuro endocrinology letters, 2011, Volume: 32 Suppl 1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; DNA Damage; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ellipticines; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Microsomes, Liver; Models, Biological; Neuroblastoma; Rats; Treatment Outcome; Tumor Cells, Cultured; Valproic Acid

2011
The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells.
    International journal of molecular sciences, 2018, Jan-05, Volume: 19, Issue:1

    Topics: Apoptosis; Cell Line, Tumor; Drug Synergism; Ellipticines; Histone Deacetylase Inhibitors; Humans; Mutagens; Neuroblastoma; Neurons; Valproic Acid

2018